01 18NEUROCRINE
01 1810912771
01 18Blank
01 18Blank
01 182037-10-10
Patent Expiration Date : 2037-10-10
US Patent Number : 10912771
Drug Substance Claim :
Drug Product Claim :
Application Number : 209241
Patent Use Code : U-3055
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2037-10-10
Patent Expiration Date : 2037-10-10
US Patent Number : 10912771
Drug Substance Claim :
Drug Product Claim :
Application Number : 218390
Patent Use Code : U-3076
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2037-10-10
Patent Expiration Date : 2037-10-10
US Patent Number : 10912771
Drug Substance Claim :
Drug Product Claim :
Application Number : 218390
Patent Use Code : U-3055
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2037-10-10
Patent Expiration Date : 2037-10-10
US Patent Number : 10912771
Drug Substance Claim :
Drug Product Claim :
Application Number : 209241
Patent Use Code : U-3076
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2037-10-10
Patent Expiration Date : 2037-10-10
US Patent Number : 10912771
Drug Substance Claim :
Drug Product Claim :
Application Number : 209241
Patent Use Code : U-1995
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2037-10-10
Patent Expiration Date : 2037-10-10
US Patent Number : 10912771
Drug Substance Claim :
Drug Product Claim :
Application Number : 209241
Patent Use Code : U-3055
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2037-10-10
Patent Expiration Date : 2037-10-10
US Patent Number : 10912771
Drug Substance Claim :
Drug Product Claim :
Application Number : 209241
Patent Use Code : U-1995
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2037-10-10
Patent Expiration Date : 2037-10-10
US Patent Number : 10912771
Drug Substance Claim :
Drug Product Claim :
Application Number : 218390
Patent Use Code : U-3076
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2037-10-10
Patent Expiration Date : 2037-10-10
US Patent Number : 10912771
Drug Substance Claim :
Drug Product Claim :
Application Number : 209241
Patent Use Code : U-3076
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2037-10-10
Patent Expiration Date : 2037-10-10
US Patent Number : 10912771
Drug Substance Claim :
Drug Product Claim :
Application Number : 218390
Patent Use Code : U-3055
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2037-10-10
